Form 4: Linde PLC Executive VP Sean Durbin Reports Stock Option Exercise and Share Sales
SEC Form 4
Executive VP of Linde PLC, Sean Durbin, reports exercising stock options and selling shares on August 16, 2024.
Summary
- Sean Durbin, Executive VP of Linde PLC, filed a Form 4 detailing changes in beneficial ownership.
- On August 16, 2024, Durbin exercised stock options to acquire 12,170 ordinary shares at a price of $154.
- Also on August 16, 2024, Durbin disposed of 8,001 shares to cover the exercise price and tax withholdings at $456.48.
- Durbin sold 4,169 ordinary shares at $456.42.
- Following these transactions, Durbin directly owns 8,150.567 ordinary shares.
- Durbin also holds various stock options and restricted stock units that vest over several years.
Sentiment
Score: 5
Explanation: This is a routine filing of stock transactions by an executive, with no clear positive or negative implications for the company's overall performance or outlook.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are closely watched by investors for insights into management's perspective on the company's value and future prospects.
Comparison to Industry Standards
- Executive compensation packages, including stock options and restricted stock units, are standard practice among large, publicly traded companies like Linde PLC.
- The vesting schedules and exercise prices of the options are typical for executive compensation plans designed to align management's interests with those of shareholders over the long term.
- Comparing Durbin's stock option grants and vesting schedules to those of executives at similar companies in the industrial gases sector (e.g., Air Products & Chemicals, or Air Liquide) would provide a benchmark for assessing the competitiveness and appropriateness of his compensation.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they represent a small fraction of the total outstanding shares.
- The exercise of stock options dilutes existing shareholders' equity slightly.
- The sale of shares by the executive may be perceived neutrally or slightly negatively by some investors, depending on their interpretation of the executive's motives.
Key Dates
| Date | Description |
|---|---|
| 02/28/2018 | Start date for vesting of stock options at $118.71. |
| 02/27/2019 | Start date for vesting of stock options at $154. |
| 03/20/2020 | Start date for vesting of stock options at $176.63. |
| 03/09/2021 | Start date for vesting of stock options at $173.13. |
| 03/08/2022 | Start date for vesting of stock options at $253.68. |
| 03/07/2023 | Start date for vesting of stock options at $270.99. |
| 03/07/2024 | Start date for vesting of stock options at $354.14. |
| 08/16/2024 | Date of stock option exercise and share sales. |
| 03/07/2025 | Start date for vesting of stock options at $465.29 and vesting date for restricted stock units. |
| 03/07/2026 | Vesting date for restricted stock units. |
| 03/07/2027 | Vesting date for restricted stock units. |
| 02/27/2028 | Expiration date for stock options at $154. |
| 03/20/2029 | Expiration date for stock options at $176.63. |
| 03/09/2030 | Expiration date for stock options at $173.13. |
| 03/08/2031 | Expiration date for stock options at $253.68. |
| 03/07/2032 | Expiration date for stock options at $270.99. |
| 03/07/2033 | Expiration date for stock options at $354.14. |
| 03/07/2034 | Expiration date for stock options at $465.29. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.